ClinicalTrials.Veeva

Menu

Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2)

U

University Hospital Bonn (UKB)

Status

Enrolling

Conditions

Portal Hypertension

Treatments

Device: TIPS procedure

Study type

Observational

Funder types

Other

Identifiers

NCT04393519
NEPTUN2

Details and patient eligibility

About

Evaluation of non-invasive prognostic parameters in patients receiving transjugular intrahepatic portosystemic shunt (TIPS) for complications of portal hypertension. Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.

Full description

NEPTUN consists of liver cirrhosis receiving transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Internal Medicine I, University of Bonn, Germany and receiving a structured routine evaluation and follow up program. The diagnosis of cirrhosis was based on clinical, hemodynamic and biochemical parameters, and ultrasound and/or biopsy criteria.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Insertion of TIPS according to guidelines

Exclusion criteria

  • Contraindication for TIPS

Trial design

1,000 participants in 1 patient group

Prospective
Description:
Prospective cohort that received TIPS from 05/12/2020 onwards
Treatment:
Device: TIPS procedure

Trial contacts and locations

1

Loading...

Central trial contact

Michael Praktiknjo, MD; Johannes Chang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems